James B. Weissman, Chief Business Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 2,301 shares at $17.50 ($40K) on 2018-09-05, disclosed to the SEC on 2018-09-06.
Scheduled sale ($40k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DRNA | SELL | 2021-02-08 | $386K | — | Filing → |
| DRNA | SELL | 2021-01-12 | $91K | — | Filing → |
| DRNA | SELL | 2020-12-03 | $220K | — | Filing → |